How vaccines can be ‘tweaked’ to combat new Covid variants
Spread of South Africa strain of coronavirus has intensified efforts to boost jab efficacy
England's deputy chief medical officer has urged Britons not to “panic” over suggestions that the Oxford-AstraZeneca jab offers only limited protection against the South African strain of coronavirus.
Professor Jonathan Van-Tam told a No. 10 press briefing yesterday that the variant was “not likely” to become the dominant strain in the UK, despite warnings from researchers that the South African version appears to be more contagious. “The stories and the headlines around variant viruses and vaccines are a bit scary - I wish they weren’t,” Van-Tam added.
However, with new Covid variants also identified in California, Brazil and the UK, attention is turning to how vaccines can be tweaked to combat mutations of the virus.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Pharmaceutical giants including Pfizer-BioNTech, Moderna and Oxford-AstraZeneca are all “looking at ways to improve their vaccines”, The Guardian reports.
Jabs that use mRNA technology, such as those developed by Pfizer-BioNTech and Moderna, are considered by experts to be easier to tweak than more traditional vaccines, such as the Oxford-AstraZeneca version.
“Blood drawn from people vaccinated with the Moderna Covid-19 vaccine had antibodies that blocked” the South Africa variant, The Verge says. But “it took around six times more of them to block this strain than the predominant form of the virus”, the site continues.
Experts are now aiming to “measure the antibody levels of people who were vaccinated but still got sick with Covid-19, and identify the cutoff where the vaccine wasn’t protective”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
The Gavi vaccine alliance says that tweaking the Pfizer-BioNTech and Moderna vaccines would involve “adjusting the code of the DNA template, which should be a relatively quick and simple process”.
Although the process has “no historical precedent”, owing to the newness of the technology involved, it “would probably involve modifying the vaccine adenovirus so it contains a slightly different piece of code matching the spike protein from the new coronavirus variant”.
In a note of optimism, Gavi adds that “the production of a new influenza vaccine each year demonstrates that it is possible to adapt existing vaccines to keep up with viral mutations”.
This confidence has been echoed by some Covid vaccine producers, including BioNTech, whose experts are estimating that they can make a tweaked jab within six weeks.
However, the Oxford-AstraZeneca team say a version of their jab that is able to better tackle the South African strain may not be ready until autumn.
Create an account with the same email registered to your subscription to unlock access.
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
What's next for US interest rates?
The Explainer Stubborn inflation forestalls anticipated rate cuts
By Becca Stanek, The Week US Published
-
Russia rattles nuclear saber, orders tactical nuke drills
Speed Read President Vladimir Putin has ordered Russian military to hold nuclear weapons drills in response to Western "threats"
By Peter Weber, The Week US Published
-
Five top new women's watches
The Week Recommends From dancing diamonds to reconfigured classics, these models were recently revealed at Watches & Wonders Geneva 2024
By Alexandra Zagalsky Published
-
Covid four years on: have we got over the pandemic?
Today's Big Question Brits suffering from both lockdown nostalgia and collective trauma that refuses to go away
By Chas Newkey-Burden, The Week UK Published
-
The hollow classroom
Opinion Remote school let kids down. It will take much more than extra tutoring for kids to recover.
By Mark Gimein Published
-
Excess screen time is making children only see what is in front of them
Under the radar The future is looking blurry. And very nearsighted.
By Devika Rao, The Week US Published
-
Covid-19: what to know about UK's new Juno and Pirola variants
in depth Rapidly spreading new JN.1 strain is 'yet another reminder that the pandemic is far from over'
By Arion McNicoll, The Week UK Published
-
Long-term respiratory illness is here to stay
The Explainer Covid is not the only disease with a long version
By Devika Rao, The Week US Published
-
Covid inquiry: the most important questions for Boris Johnson
Talking Point Former PM has faced weeks of heavy criticism from former colleagues at the public hearing
By The Week Staff Published
-
China's pneumonia cases: should we be worried?
The Explainer Experts warn against pushing 'pandemic panic button' following outbreak of respiratory illness
By Keumars Afifi-Sabet, The Week UK Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published